ALLOZYMES
Allozymes is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We develop sensitive, accurate, and generic assays to detect enzymatic reactions, proprietary microfluidic chips, and proteomics technologies to take enzyme development to the next level.
ALLOZYMES
Industry:
B2B Biotechnology Health Care
Founded:
2019-12-04
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.allozymes.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
20.26 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Font Awesome Global Site Tag Google Universal Analytics
Similar Organizations
ApexQubit
ApexQubit is a biotechnology company that is harnessing frontier technologies for discovery of new medicines and better health for humanity.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
PlusLife Biotech
PlusLife Biotech is driven to creating newer molecular diagnostic tools using a new generation of genetic technologies.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Zhenzhun Biotech
Zhenzhun Biotech is a bio-tech enterprise integrating R&D, production and sales of in vitro diagnostic equipment consumables.
Current Employees Featured
Founder
Investors List
ID Capital
ID Capital investment in Series A - Allozymes
Seventure Partners
Seventure Partners investment in Series A - Allozymes
NUS Technology Holdings
NUS Technology Holdings investment in Series A - Allozymes
Xora Innovation
Xora Innovation investment in Series A - Allozymes
SOSV
SOSV investment in Series A - Allozymes
HAX
HAX investment in Series A - Allozymes
Thia Ventures
Thia Ventures investment in Series A - Allozymes
Entrepreneur First
Entrepreneur First investment in Series A - Allozymes
Transpose Platform Management
Transpose Platform Management investment in Series A - Allozymes
Entrepreneur First
Entrepreneur First investment in Seed Round - Allozymes
Official Site Inspections
http://www.allozymes.com Semrush global rank: 4.78 M Semrush visits lastest month: 1.88 K
- Host name: ec2-54-243-86-28.compute-1.amazonaws.com
- IP address: 54.243.86.28
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Allozymes"
About - Allozymes
The birth of Allozymes was instantly marked by a pivotal challenge: establishing a dedicated laboratory during the COVID-19 pandemic in the small city-state of Singapore. However, this crucial infrastructure ultimately enabled …See details»
Allozymes - Crunchbase Company Profile & Funding
Allozymes is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We develop sensitive, accurate, and generic assays to detect …See details»
Allozymes - LinkedIn
Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across sectors.See details»
Allozymes Company Profile - Office Locations, Competitors ... - Craft
Allozymes has 5 employees at their 1 location. See insights on Allozymes including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Allozymes - VentureRadar
"Allozymes is applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. The company’s first target application is to transform …See details»
About Allozymes. - Ingredients Network
About Company description. Accelerating Nature’s Manufacturing Machinery. Allozymes applies its proprietary platform technology to rapidly develop novel enzymes, revolutionizing the way that industries manufacture complex natural …See details»
Technology - Allozymes
"Allozymes' revolutionary platform combines advanced computational design, ultra-high-throughput microfluidics, and machine learning to rapidly screen millions of enzyme variants and identify those with desired functions. This …See details»
Accelerating the Bio Economy: How Singapore-based startup …
Mar 3, 2023 This is where enzyme discovery, design and development kick in. Combining the power of data and biology, Allozymes is developing a next-gen synthetic biology platform, …See details»
Allozymes! Have you heard of them? - LinkedIn
Dec 20, 2023 Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the …See details»
Allozymes - HAX – Hands-on Venture Capital for Hard Tech
Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M. May 3, 2024. ... Company/Organization. Hidden. Company. Hidden. Company Slug. Hidden. Receiver …See details»
Allozymes looks to upend chemical manufacturing with rapid …
Jul 6, 2021 Allozymes was founded by Peyman Salehian (CEO) and Akbar Vahidi (CTO), two Iranian chemical engineers who met while pursuing their PhDs at the National University of …See details»
Allozymes - Funding, Financials, Valuation & Investors - Crunchbase
Allozymes is a biotech company that accelerating enzyme evolution for the sustainable future of industries. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How …See details»
Partner with us - Allozymes
Contact us today to explore how Allozymes can help you. LinkedIn; Twitter; Instragram; Everything Allozymes, straight to your inbox. Partner with us; Technology; Impact; About; …See details»
Enzyme Technology Alliance Welcomes Allozymes and SpinChem
Oct 18, 2023 Synergy of Complementary Technologies: Allozymes brings their pioneering microfluidics technology to the alliance, enabling the optimization of enzymes with remarkable …See details»
Peyman Salehian - Co-founder & CEO at Allozymes - The Org
As a serial entrepreneur, he now leads Allozymes to spearhead an advanced technology to revolutionize biotech adoption in different industries. He started his first company at 22 …See details»
Allozymes' enzyme engineering is 'a paradigm shift' in biotech ...
Allozymes uses microfluidics technology to build and test millions of enzymes a day – the company says this is significantly faster and more cost-effective than current robotics …See details»
Resources - allozymes.com
Oct 14, 2024 How does Allozymes differentiate itself from other enzyme engineering companies? Our unique combination of advanced microfluidics, ultra-high-throughput …See details»
How Allozymes Engineers the Right Enzymes | NUS Tech Portal
To improve the process and benefit both industry and environment, co-founders Dr Peyman Salehian and Dr Akbar Vahidi launched Allozymes. W ith support from the National University …See details»
Allozymes
NEW Allozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement Ingredients. We're a team of scientists, creators, and innovators unlocking …See details»
Impact - Allozymes
Allozymes uses 24x less solvent than traditional extraction methods. The process allows for scalable and controlled production of phytoene without relying on resource-intensive …See details»